Table 2: Patient characteristics.

Characteristics Number of cases %

Patients 18
 Median years of age (range) 56 (38–79)
 Gender, male/female 5/13 28/72
 ECOG PS, 0/1 16/289/11
 Median body height of patients (range)157.5 cm (147.3–175)
 Median body weight of patients (range)50.6 kg (39.9–76.5)
 Median body surface area of patients (range)1.5 m2 (1.33–1.83)
 Median quantity of administered R (range)560 mg (498–680)
Cardiac function (pretreatment)
 Median level of BNP (range)15.1 pg/mL (5.8–55.5)
 Median % of LVEF (range) 73% (58.3–81.8)
Diagnosis
 Follicular lymphoma (FL), grade 1 10 56
 FL + diffuse large B-cell lymphoma 2 11
 Extranodal marginal zone lymphoma 1 6
 Nodal marginal zone lymphoma 1 6
 Waldenström’s macroglobulinemia 1 6
 Mantle cell lymphoma 1 6
 Diffuse large B-cell lymphoma 2 11
Regimens
 R-CHOP 2 11
 R-CVP 2 11
 R (as maintenance therapy) 14 78
Total cycles of R (range, for each patient) 88 (4–8)

ECOG: Eastern Cooperative Oncology Group; PS: performance status; R: rituximab; BNP: brain natriuretic peptide; LVEF: left ventricular ejection fraction; R-CHOP: rituximab, cyclophosphamide, doxorubicin, vincristine, and predonisolone; R-CVP: rituximab, cyclophosphamide, vincristine, and predonisolone.